Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation

Bone Marrow Transplantation

Volumn 33, Issue 6, 2004, Pages 597-604

  Maitra, B ^a   Szekely, E ^a   Gjini, K ^a   Laughlin, M J ^a,b   Dennis, J ^c   Haynesworth, S E ^c   Koc O N ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b Division of Hematology/Oncology   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GVHD; Immunosuppression; MSC; Stem cell; Stormal cell

Indexed keywords

TUBERCULIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ARTICLE; BLOOD DONOR; BONE MARROW; CELL COUNT; CELL FREE SYSTEM; CELL LINE; CLINICAL OBSERVATION; CONTROLLED STUDY; DATA ANALYSIS; FIBROBLAST CULTURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SKIN CELL; STROMA CELL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MESODERM; MICE; MICE, INBRED NOD; MICE, SCID; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 1842483153     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704400     Document Type: Article

References (31)

1. Koç O, Lazarus H. Mesenchymal stem cells heading to the clinic. Bone Marrow Transplant 2001; 27: 235-239.
2. Bianco P, Constantini M, Dearden L, Bonucci E. Alkaline phosphatase positive precursors of adipocytes in the human bone marrow. Br J Haematol 1988; 68: 401-411.
3. Haynesworth S, Goshima J, Goldberg V, Caplan A. Characterization. of cells with osteogenic potential from human marrow. Bone 1992; 13: 81-88.
4. Pittinger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
5. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
6. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-2625.
7. Toksoz D, Zsebo K, Smith K et al. Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992; 89: 7350-7354.
8. Clark B, Keating A. Biology of bone marrow stroma. Ann NY Acad Sci 1995; 770: 70-88.
9. Majumdar M, Thiede M, Haynesworth S et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2001; 9: 841-848.
10. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 186-192.
11. LeBlanc K, Tammik L, Sundberg B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
12. Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-397.
13. Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838.
14. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 72: 1653-1655.
15. Caplan A. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
16. Haynesworth S, Baber M, Caplan A. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69-80.
17. Koç O, Gerson S, Cooper B et al. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high dose chemotherapy. J Clin Oncol 2000; 18: 307-316.
18. Koç O, Day J, Nieder M et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-222.
19. Schafer I, Pandy M, Ferguson R, Davis B. Comparative observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: Growth kinetics, packing density at confluence and surface morphology. Mech Ageing Dev 1985; 31: 275-293.
20. Dennis J, Merriam A, Awadallah A et al. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Min Res 1999; 14: 700.
21. Tary-Lehmann M, Hricik D, Justice A et al. Enzyme-linked immunosorbent assay spot detection of interferon and interleukin-5 producing cells as a predictive marker for renal allograft failure. Transplantation 1998; 66: 219-224.
22. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
23. Anklesaria P, Kase K, Glowacki J et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987; 1987: 7681-7685.
24. Nolta J, Hanley M, Kohn D. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors. Blood 1994; 83: 3041-3051.
25. Almeida-Porada G, Porada C, Tran N, Zanjani E. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620-3627.
26. Noort WA, Kruisselbrink AB, Anker PS et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2002; 30: 870-878.
27. Angelopoulou M, Novelli E, Grove J et al. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 2003; 31: 413-420.
28. Lee K, Gerson SL, Maitra B, Koc ON. G156A MGMT-transduced human mesenchymal stem cells can be selectively enriched by O6-benzylguanine and BCNU. J Hematother Stem Cell Res 2001; 10: 691-701.
29. Sandmaier B, Strob R, Kniley J et al. Evidence of allogencic stromal engraftment in bone marrow using canine mesenchymal stem cells. Blood 1998; 92: 116a.
30. Devine S, Bartholomew A, Mahmud N et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244-255.
31. Krampera M, Glennie S, Dyson J et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.